Amgen

Enbrel gets black-box infection warning

admin — Fri, 02 May 2008 06:59:56 -0400

Enbrel's new black box is now official. Wyeth and Amgen have put the final touches on a Read more...

AAMC: Ban pharma gifts at med schools

admin — Mon, 28 Apr 2008 06:59:57 -0400

Will all medical schools bar the door to pharma giveaways? The Association of American Medical Colleges hopes so. After two years of study, the influential group drafted a policy that would ban drug Read more...

AZ, Amgen earnings flat; Shire sales leap

admin — Fri, 25 Apr 2008 06:59:54 -0400

It's a mixed bag of drugmaker earnings reports today, with two biggies posting flat results and two smaller firms chalking up respectable gains.AstraZeneca's profits suffered under restructuring Read more...

Emerging markets drive global growth

admin — Wed, 16 Apr 2008 06:59:56 -0400

Without emerging healthcare markets like China and India, global pharma would be in a world of hurt. The global market for meds reached $712 billion last year, according to a new report from IMS Read more...

Arms twisted, pharma promises disclosure

admin — Fri, 11 Apr 2008 06:59:55 -0400

Pharma knows that self-regulation is the best kind. That's why 12 drug and device makers have promised Sen. Chuck Grassley that they are working on plans to disclose CME grants. You know, the money Read more...

Takeda offers $8.8B for Millennium

admin — Thu, 10 Apr 2008 06:59:58 -0400

Takeda Pharmaceutical is placing an $8.8 billion bet on cancer meds. The Japanese drugmaker has offered $25 per share for Millennium Pharmaceuticals, which not only makes the lucrative blood-cancer Read more...

Roche appeals Mircera injunction

admin — Thu, 10 Apr 2008 06:59:56 -0400

Roche is appealing to a higher power on Mircera. The Swiss drugmaker is appealing a lower court ruling barring Read more...

Grassley: Amgen doc rebates skyrocket

admin — Fri, 04 Apr 2008 07:59:57 -0400

Another day, another Grassley letter. You'll recall that earlier this week, Sen. Chuck Grassley demanded documents from Amgen relating to the company's promotions of its anemia drugs. Now, Grassley Read more...

ALSO NOTED: Takeda prevails in Actos patent suit; Analyst gets peek at Biovail founder's laptop;

admin — Fri, 04 Apr 2008 07:59:50 -0400

> The U.S. Supreme court refused to reconsider an appeals court ruling that upheld Takeda's patent on its diabetes treatment Actos, a decision that keeps Alphapharm from launching a generic Read more...

SPOTLIGHT: Amgen pays CEO 29 percent less

admin — Wed, 02 Apr 2008 07:59:52 -0400

It's a pay cut for Amgen Chairman and CEO Kevin Sharer (photo). His 2007 compensation dropped by nearly 29 percent to Read more...